$HBIO
HARVARD BIOSCIENCE INC

2014 Q4 Form 10-Q Financial Statement

#000117184314005331 Filed on November 06, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $30.36M $25.45M $25.14M
YoY Change 9.01% 1.24% -3.7%
Cost Of Revenue $16.50M $14.01M $13.84M
YoY Change 4.4% 1.21% -2.1%
Gross Profit $13.86M $11.44M $11.30M
YoY Change 15.06% 1.27% -5.6%
Gross Profit Margin 45.66% 44.96% 44.95%
Selling, General & Admin $9.570M $8.243M $8.820M
YoY Change 27.94% -6.54% -7.18%
% of Gross Profit 69.03% 72.04% 78.06%
Research & Development $1.560M $1.059M $1.934M
YoY Change -191.76% -45.24% 3.92%
% of Gross Profit 11.25% 9.26% 17.12%
Depreciation & Amortization $1.090M $930.0K $960.0K
YoY Change 13.54% -3.13% -5.88%
% of Gross Profit 7.86% 8.13% 8.5%
Operating Expenses $11.74M $10.02M $10.89M
YoY Change -9.66% -7.97% 0.67%
Operating Profit $2.121M $1.425M $414.0K
YoY Change -323.5% 244.2% -64.19%
Interest Expense -$210.0K $239.0K $276.0K
YoY Change -41.67% -13.41% 87.76%
% of Operating Profit -9.9% 16.77% 66.67%
Other Income/Expense, Net -$949.0K -$469.0K -$358.0K
YoY Change 197.49% 31.01% 101.12%
Pretax Income $1.172M $956.0K $56.00K
YoY Change -192.43% 1607.14% -94.27%
Income Tax $1.191M $323.0K $105.0K
% Of Pretax Income 101.62% 33.79% 187.5%
Net Earnings -$19.00K $633.0K -$984.0K
YoY Change -97.49% -164.33% 639.85%
Net Earnings / Revenue -0.06% 2.49% -3.91%
Basic Earnings Per Share $0.00 $0.02 -$0.03
Diluted Earnings Per Share $0.00 $0.02 -$0.03
COMMON SHARES
Basic Shares Outstanding 32.42M shares 32.34M shares 30.57M shares
Diluted Shares Outstanding 33.41M shares 30.57M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.10M $26.70M $36.90M
YoY Change -45.35% -27.64% 81.77%
Cash & Equivalents $14.13M $26.73M $36.90M
Short-Term Investments
Other Short-Term Assets $4.742M $4.062M $1.600M
YoY Change 25.75% 153.88% -46.6%
Inventory $20.53M $18.06M $18.00M
Prepaid Expenses
Receivables $16.14M $14.28M $13.40M
Other Receivables $4.800M $4.000M $4.000M
Total Short-Term Assets $57.06M $65.00M $73.90M
YoY Change -6.07% -12.04% 25.76%
LONG-TERM ASSETS
Property, Plant & Equipment $5.190M $4.109M $4.600M
YoY Change 18.63% -10.67% 12.28%
Goodwill $39.82M $35.94M
YoY Change 8.79%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $380.0K $359.0K $12.80M
YoY Change 20.25% -97.2% 19004.48%
Total Long-Term Assets $78.85M $71.13M $74.40M
YoY Change 5.55% -4.4% 3.6%
TOTAL ASSETS
Total Short-Term Assets $57.06M $65.00M $73.90M
Total Long-Term Assets $78.85M $71.13M $74.40M
Total Assets $135.9M $136.1M $148.3M
YoY Change 0.34% -8.21% 13.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.294M $5.100M $4.700M
YoY Change 34.43% 8.51% 13.5%
Accrued Expenses $4.452M $4.132M $4.400M
YoY Change -12.33% -6.09% 16.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M $5.000M $3.000M
YoY Change 0.0% 66.67%
Total Short-Term Liabilities $18.10M $15.63M $13.50M
YoY Change 12.52% 15.76% 41.64%
LONG-TERM LIABILITIES
Long-Term Debt $16.45M $18.20M $20.50M
YoY Change -16.71% -11.22% 33.99%
Other Long-Term Liabilities $4.600M $5.400M $6.200M
YoY Change -8.0% -12.9% 26.53%
Total Long-Term Liabilities $16.45M $18.20M $26.70M
YoY Change -16.71% -31.84% 74.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.10M $15.63M $13.50M
Total Long-Term Liabilities $16.45M $18.20M $26.70M
Total Liabilities $40.45M $39.35M $40.50M
YoY Change -1.29% -2.83% 34.03%
SHAREHOLDERS EQUITY
Retained Earnings -$92.68M -$92.67M
YoY Change -2.48%
Common Stock $207.1M $205.8M $382.0K
YoY Change 2.08% 53769.9% -99.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 7.746M shares 7.746M shares
Shareholders Equity $95.47M $96.78M $107.8M
YoY Change
Total Liabilities & Shareholders Equity $135.9M $136.1M $148.3M
YoY Change 0.34% -8.21% 13.57%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$19.00K $633.0K -$984.0K
YoY Change -97.49% -164.33% 639.85%
Depreciation, Depletion And Amortization $1.090M $930.0K $960.0K
YoY Change 13.54% -3.13% -5.88%
Cash From Operating Activities $1.260M $600.0K $1.430M
YoY Change 0.8% -58.04% -43.03%
INVESTING ACTIVITIES
Capital Expenditures -$790.0K -$480.0K -$510.0K
YoY Change 49.06% -5.88% -5.56%
Acquisitions
YoY Change
Other Investing Activities -$11.59M $0.00 $1.780M
YoY Change -16657.14% -100.0% 5833.33%
Cash From Investing Activities -$12.37M -$480.0K $1.270M
YoY Change 2589.13% -137.8% -349.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.090M 1.360M -750.0K
YoY Change -91.27% -281.33% 1.35%
NET CHANGE
Cash From Operating Activities 1.260M 600.0K 1.430M
Cash From Investing Activities -12.37M -480.0K 1.270M
Cash From Financing Activities -1.090M 1.360M -750.0K
Net Change In Cash -12.20M 1.480M 1.950M
YoY Change 4.36% -24.1% 54.76%
FREE CASH FLOW
Cash From Operating Activities $1.260M $600.0K $1.430M
Capital Expenditures -$790.0K -$480.0K -$510.0K
Free Cash Flow $2.050M $1.080M $1.940M
YoY Change 15.17% -44.33% -36.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14281000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
18063000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26734000 USD
CY2014Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1265000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
592000 USD
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
29000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
359000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
119000 USD
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18200000 USD
CY2014Q3 us-gaap Goodwill
Goodwill
35938000 USD
CY2014Q3 us-gaap Assets
Assets
136128000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15628000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4132000 USD
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12765000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
39352000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
640000 USD
CY2014Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
5000000 USD
CY2014Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5405000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16691000 USD
CY2014Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
823000 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
395000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136128000 USD
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
205388000 USD
CY2014Q3 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
96776000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92670000 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
94485000 USD
CY2013Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19009000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95039000 USD
CY2013Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
5000000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
15777000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
160000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19750000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5078000 USD
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1289000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135460000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4109000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
60750000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
13116000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4375000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2290000 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4174000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
202446000 USD
CY2013Q4 us-gaap Assets
Assets
135460000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25771000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
586000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
390000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
40975000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
99000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13884000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
36605000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16085000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
316000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
4980000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4682000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1547000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
358000 USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39384974 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31639467 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32376764 shares
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
312000 USD
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40122271 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
12049000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-74000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-948000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Revenues
Revenues
25448000 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14006000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
11442000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4113000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4130000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1059000 USD
CY2014Q3 us-gaap Restructuring Charges
RestructuringCharges
97000 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
618000 USD
CY2014Q3 us-gaap Other General Expense
OtherGeneralExpense
0 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
10017000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1425000 USD
CY2014Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
239000 USD
CY2014Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
19000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-249000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-469000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
956000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
323000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
633000 USD
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
633000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
414000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-357000 USD
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-983000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-48000 USD
CY2013Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
10000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2013Q3 us-gaap Other General Expense
OtherGeneralExpense
268000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4646000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
276000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-935000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2013Q3 us-gaap Restructuring Charges
RestructuringCharges
96000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
57000 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13838000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
11299000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
10885000 USD
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
2381000 USD
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3168000 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
23000 USD
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-23000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-29000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-31000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2481000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1404000 USD
us-gaap Revenues
Revenues
78299000 USD
us-gaap Revenues
Revenues
77317000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42818000 USD
us-gaap Gross Profit
GrossProfit
35481000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13102000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12378000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3316000 USD
us-gaap Restructuring Charges
RestructuringCharges
349000 USD
us-gaap Other General Expense
OtherGeneralExpense
0 USD
us-gaap Operating Expenses
OperatingExpenses
30984000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4497000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-148000 USD
us-gaap Interest Expense
InterestExpense
752000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
45000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-397000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1252000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3245000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
871000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2374000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Net Income Loss
NetIncomeLoss
2374000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-100000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-57000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-651000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Interest Expense
InterestExpense
650000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2485000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-783000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-26000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13227000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1074000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
540000 USD
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.06
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
725000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2051000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-577000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-87000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-69000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
977000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
28000 USD
us-gaap Operating Expenses
OperatingExpenses
33163000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41669000 USD
us-gaap Restructuring Charges
RestructuringCharges
51000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
227000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1015000 USD
us-gaap Gross Profit
GrossProfit
35648000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3036000 USD
us-gaap Other General Expense
OtherGeneralExpense
1788000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1955000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1702000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13106000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
484000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1534000 USD
us-gaap Depreciation
Depreciation
913000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-8000 USD
hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-120000 USD
hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
37000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-34000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
46000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
259000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
557000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2649000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
446000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-486000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-38000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-107000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
89000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3088000 USD
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-1224000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
76000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1148000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2200000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3750000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1415000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-842000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
963000 USD
us-gaap Interest Paid
InterestPaid
757000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
451000 USD
us-gaap Depreciation
Depreciation
990000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
440000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000 USD
hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
51000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
69000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2000000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-15000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
406000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
615000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
143000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2811000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20681000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36931000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16250000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18820000 USD
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-1089000 USD
hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-57000 USD
CY2014Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
263000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1244000 USD
us-gaap Interest Paid
InterestPaid
534000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12547000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
629000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
66000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div><p style='text-align:left;margin-top:9pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;' >2</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' >.</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;' > Recently Issued Accounting Pronouncements</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Calibri;font-size:11pt;font-weight:bold;margin-left:0pt;' > </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >&#8220;Revenue from Contracts with Customers,&#8221;</font><font style='font-family:Times New Roman;font-size:10pt;' > a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance in U.S. GAAP. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. This standard will be effective as of the beginning of the Company&#8217;s 2017 fiscal year. The Company is assessing the new standard and has not yet determined the impact to the consolidated financial statements.</font><font style='font-family:Times New Roman;font-size:10pt;' > </font></p></div>
CY2014Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
40816000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-24125000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41740000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-22731000 USD
CY2014Q3 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
37203000 USD
CY2013Q4 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
37894000 USD
CY2013Q4 hbio Total Intangible Assets
TotalIntangibleAssets
79634000 USD
CY2014Q3 hbio Total Intangible Assets
TotalIntangibleAssets
78019000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14445000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-667000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1600000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1800000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2000000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2200000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2400000 USD
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9140000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7039000 USD
CY2014Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
512000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
752000 USD
CY2014Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
8411000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7986000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18406000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14297000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5696 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019 pure
CY2013Q4 hbio Date Separation Plan Completed
DateSeparationPlanCompleted
November 1, 2013
CY2013Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-10-21
CY2013Q4 hbio Spinoff Distribution Ratio
SpinoffDistributionRatio
1 for 4
CY2013Q4 hbio Date Entered Into Commerical Agreements With Spinnee
DateEnteredIntoCommericalAgreementsWithSpinnee
31-Oct-13
CY2013Q4 hbio Lost Value Adjustment To Share And Exercise Price Of Existing Options
LostValueAdjustmentToShareAndExercisePriceOfExistingOptions
0.8 pure
CY2013Q4 hbio Percent Lost Value Provided Back To Option Holder
PercentLostValueProvidedBackToOptionHolder
0.2 pure
CY2013Q4 hbio Lost Value Adjustment To Share Amount Of Existing Outstanding Restricted Stock Units
LostValueAdjustmentToShareAmountOfExistingOutstandingRestrictedStockUnits
0.8 pure
CY2013Q4 hbio Percent Lost Value Provided Back To Restricted Stock Unit Holder
PercentLostValueProvidedBackToRestrictedStockUnitHolder
0.2 pure
CY2013Q4 hbio Asset Transfer As Part Of Spinoff
AssetTransferAsPartOfSpinoff
900000 USD
CY2013Q1 hbio Date Private Letter Ruling
DatePrivateLetterRuling
22-Mar-13
CY2013Q2 hbio Date Supplemental Ruling To Private Letter Ruling
DateSupplementalRulingToPrivateLetterRuling
28-Jun-13
CY2013Q4 hbio Taxable Spinoff From Percent Acquired Stock
TaxableSpinoffFromPercentAcquiredStock
0.5 pure
CY2013Q4 hbio Transfer Of Cash And Cash Equivalents To Hart
TransferOfCashAndCashEquivalentsToHART
15000000 USD
CY2013Q4 hbio Incremental Options Granted Due To Hart Spinoff
IncrementalOptionsGrantedDueToHartSpinoff
1700000 shares
CY2013Q4 hbio Incremental Units Granted Due To Hart Spinoff
IncrementalUnitsGrantedDueToHartSpinoff
100000 shares
CY2013 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-179000 USD
CY2013 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
262000 USD
CY2012Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
222000 USD
CY2014Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 USD
CY2013Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
84000 USD
CY2013Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
209000 USD
CY2014Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
200000 USD
CY2014Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
147000 USD
CY2013Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
137000 USD
CY2013Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-65000 USD
CY2014Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-40000 USD
CY2014Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
93000 USD
CY2013Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
221000 USD
CY2014Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2013Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
235000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
649000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
583000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
478000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-181000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
302000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
616000 USD
us-gaap Defined Benefit Plans Estimated Future Employer Contributions In Current Fiscal Year
DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear
200000 USD
CY2014Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000 USD
CY2014Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
5400000 USD
CY2013Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
4900000 USD
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
600000 USD
hbio Defined Benefit Plan Unrealized Loss Gain
DefinedBenefitPlanUnrealizedLossGain
600000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1816000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1351000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1329000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1299000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1160000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4941000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11896000 USD
CY2013Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1100000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
900000 USD
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-08-31
CY2014Q3 hbio Expansion Area Of Real Estate Property
ExpansionAreaOfRealEstateProperty
22000 sqft
CY2014Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
83000 sqft
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
993000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.14
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-832263 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.69
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6690845 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6316169 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.42
CY2014Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.4
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
306397 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
463973 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-233098 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.32
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.3
hbio Stock Issued During Period Gross Stock Options Exercised
StockIssuedDuringPeriodGrossStockOptionsExercised
535413 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-40878 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
116400 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.12
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M4D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.572 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5683 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0179 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118 pure
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y0M0D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M0D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M20D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
615000 USD
CY2013Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000 USD
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
500000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
763000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1534000 USD
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30574815 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32341586 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30574815 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33414857 shares
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1073271 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32079744 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30154788 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1607678 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1017268 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33097012 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31762466 shares
CY2014Q3 hbio Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.2 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
0.85 pure
CY2014Q3 hbio Employee Stock Purchase Plan Shares Authorized
EmployeeStockPurchasePlanSharesAuthorized
750000 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
558456 shares
CY2014Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
31116 shares
CY2013Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
27305 shares
hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.2
CY2014Q3 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.64
CY2013Q3 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
0
hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.64
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2449873 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6316169 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2535314 shares
CY2013Q4 us-gaap Secured Debt
SecuredDebt
24750000 USD
CY2014Q3 us-gaap Secured Debt
SecuredDebt
23200000 USD
CY2014Q3 hbio Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold
LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold
6000000 USD
CY2014Q3 hbio Lender Approval To Fund Acquisition With Equity In Excess Of Threshold
LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold
10000000 USD
CY2009Q3 hbio Previous Approved Credit Facility
PreviousApprovedCreditFacility
20000000 USD
CY2013Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000 USD
CY2013Q1 hbio Ddtl Threshold For Dollar For Dollar Reduction In Revolving Line
DdtlThresholdForDollarForDollarReductionInRevolvingLine
10000000 USD
CY2009Q3 hbio Interest Rate In Excess Of Libor On Credit Facility
InterestRateInExcessOfLiborOnCreditFacility
0.03 pure
CY2014Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
20300000 USD
CY2014Q3 hbio Minimun Percentage Of Term Loan And Delayed Draw Term Loan On Which Interest Rate Required To Be Fixed
MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed
0.5 pure
CY2013Q4 hbio Transferof Delayed Draw Down Term Loan Capacity To Revolver Capacity
TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity
5000000 USD
CY2014Q3 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
14500000 USD
CY2013Q4 invest Derivative Notional Amount
DerivativeNotionalAmount
17500000 USD
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
-49000 USD
us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-57000 USD
CY2014Q3 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
23000 USD
CY2013Q3 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-23000 USD
us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-69000 USD
us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-26000 USD
us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-100000 USD
CY2013Q3 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-29000 USD
CY2014Q3 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-31000 USD
CY2014Q3 us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
100000 USD
CY2014Q3 hbio Derivative Interest Rate Swap Effective Percentage
DerivativeInterestRateSwapEffectivePercentage
1 pure
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.338 pure
CY2013Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.842 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268 pure
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
CY2013Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
0 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
65001000 USD
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1546000 USD
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4062000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-466000 USD
hbio Proceeds From Sale Of Discontinued Operations
ProceedsFromSaleOfDiscontinuedOperations
0 USD
hbio Proceeds From Sale Of Discontinued Operations
ProceedsFromSaleOfDiscontinuedOperations
1709000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
hbio Additions To Catalog Costs
AdditionsToCatalogCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-292000 USD
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32419655 shares
CY2014Q3 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
44000 USD
us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
125000 USD
CY2014Q3 hbio Transition Services Charged To Spinnee
TransitionServicesChargedToSpinnee
18000 USD
hbio Transition Services Charged To Spinnee
TransitionServicesChargedToSpinnee
119000 USD
CY2014Q3 hbio Distribution Revenues From Spinnee
DistributionRevenuesFromSpinnee
45000 USD
hbio Distribution Revenues From Spinnee
DistributionRevenuesFromSpinnee
154000 USD

Files In Submission

Name View Source Status
0001171843-14-005331-index-headers.html Edgar Link pending
0001171843-14-005331-index.html Edgar Link pending
0001171843-14-005331.txt Edgar Link pending
0001171843-14-005331-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_110614.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hbio-20140930.xml Edgar Link completed
hbio-20140930.xsd Edgar Link pending
hbio-20140930_cal.xml Edgar Link unprocessable
hbio-20140930_def.xml Edgar Link unprocessable
hbio-20140930_lab.xml Edgar Link unprocessable
hbio-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending